Ann Rheum Dis

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miyanishi, K.
Right arrow Articles by Iwamoto, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miyanishi, K.
Right arrow Articles by Iwamoto, Y.
Ann Rheum Dis 1999;58:514-516 ( August )

Concise report

Increased level of apolipoprotein B/apolipoprotein A1 ratio as a potential risk for osteonecrosis Keita Miyanishi, Takuaki Yamamoto, Takahiko Irisa, Yasuo Noguchi, Yoichi Sugioka, Yukihide Iwamoto

Department of Orthopaedic Surgery, Faculty of Medicine, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan

Correspondence to: Dr T Yamamoto.

Accepted for publication 6 April 1999

OBJECTIVE---This study was performed to investigate whether a high ratio of apolipoprotein B to apolipoprotein A1 (apo B/apo A1 ratio) is significantly associated with the risk of developing non-traumatic osteonecrosis of the femoral head (ON).
METHODS---Fifty consecutive non-traumatic ON cases were compared with 50 age and sex matched controls, using both univariate and stepwise discriminant analyses, regarding the factors of corticosteroid, alcohol, cigarettes, cholesterol, triglyceride, and apo B/apo A1 ratio. To eliminate the possibility that ON or osteoarthritic change itself can increase the apo B/apo A1 ratio, a further 32 consecutive cases comprising nine traumatic ON and 23 osteoarthritis (OA) patients were analysed using Scheffe's test.
RESULTS---There was a significant association between a high apo B/apo A1 ratio and the development of non-traumatic ON with both univariate (p=0.0001) and stepwise discriminant analyses (partial r2=0.1239, p=0.0004). The apo B/apo A1 ratio in the non-traumatic ON group was significantly higher than that in the traumatic ON (p<0.01), control (p<0.001), or the OA groups (p<0.001).
CONCLUSION---A high apo B/apo A1 ratio is significantly associated with the risk of developing ON. This ratio may be useful for assessing the potential risk of developing osteonecrosis.


© 1999 by Annals of the Rheumatic Diseases



This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
K. Miyanishi, Y. Kamo, H. Ihara, T. Naka, M. Hirakawa, and Y. Sugioka
Risk factors for dysbaric osteonecrosis
Rheumatology, July 1, 2006; 45(7): 855 - 858.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
M. A. Mont, L. C. Jones, and D. S. Hungerford
Nontraumatic Osteonecrosis of the Femoral Head: Ten Years Later
J. Bone Joint Surg. Am., May 1, 2006; 88(5): 1117 - 1132.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
K. Miyanishi, T. Yamamoto, T. Irisa, G. Motomura, S. Jingushi, K. Sueishi, and Y. Iwamoto
Effects of different corticosteroids on the development of osteonecrosis in rabbits
Rheumatology, March 1, 2005; 44(3): 332 - 336.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
K. Miyanishi, T. Yamamoto, T. Irisa, A. Yamashita, S. Jingushi, Y. Noguchi, and Y. Iwamoto
A high low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio as a potential risk factor for corticosteroid-induced osteonecrosis in rabbits
Rheumatology, February 1, 2001; 40(2): 196 - 201.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 1999 BMJ Publishing Group Ltd & European League Against Rheumatism